Andrea G. Bree

566 total citations
12 papers, 352 citations indexed

About

Andrea G. Bree is a scholar working on Immunology, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andrea G. Bree has authored 12 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Physiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andrea G. Bree's work include Asthma and respiratory diseases (4 papers), IL-33, ST2, and ILC Pathways (3 papers) and T-cell and B-cell Immunology (3 papers). Andrea G. Bree is often cited by papers focused on Asthma and respiratory diseases (4 papers), IL-33, ST2, and ILC Pathways (3 papers) and T-cell and B-cell Immunology (3 papers). Andrea G. Bree collaborates with scholars based in United States, Canada and Germany. Andrea G. Bree's co-authors include Franklin Schlerman, Samuel J. Goldman, Ken Dower, Lih‐Ling Lin, David Hepworth, Bruce A. Lefker, Michael Bowman, Cédric Hubeau, Eicke Latz and J. Perry Hall and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and Journal of Allergy and Clinical Immunology.

In The Last Decade

Andrea G. Bree

12 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea G. Bree United States	7	169	160	80	48	43	12	352
Masanari Hasegawa Japan	12	235 1.4×	107 0.7×	135 1.7×	86 1.8×	65 1.5×	16	447
R W Janson United States	6	227 1.3×	81 0.5×	31 0.4×	35 0.7×	26 0.6×	6	371
Fanny Ender Germany	13	258 1.5×	126 0.8×	112 1.4×	34 0.7×	38 0.9×	15	414
C. Nilsson United States	6	222 1.3×	46 0.3×	129 1.6×	11 0.2×	37 0.9×	9	366
Albin Björk Sweden	9	122 0.7×	70 0.4×	126 1.6×	27 0.6×	17 0.4×	15	303
Amanda Rohrbach United States	5	327 1.9×	141 0.9×	41 0.5×	9 0.2×	48 1.1×	5	413
M Kagami Japan	9	171 1.0×	84 0.5×	221 2.8×	42 0.9×	32 0.7×	28	382
Yuka Nishibata Japan	10	184 1.1×	102 0.6×	28 0.3×	22 0.5×	99 2.3×	27	329
Iván Posso‐Osorio Colombia	11	112 0.7×	52 0.3×	38 0.5×	41 0.9×	34 0.8×	55	326
Luc Colas France	9	117 0.7×	92 0.6×	73 0.9×	22 0.5×	29 0.7×	19	297

Countries citing papers authored by Andrea G. Bree

Since Specialization

Citations

This map shows the geographic impact of Andrea G. Bree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea G. Bree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea G. Bree more than expected).

Fields of papers citing papers by Andrea G. Bree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea G. Bree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea G. Bree. The network helps show where Andrea G. Bree may publish in the future.

Co-authorship network of co-authors of Andrea G. Bree

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea G. Bree. A scholar is included among the top collaborators of Andrea G. Bree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea G. Bree. Andrea G. Bree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Rosin, Diane L., Shuqiu Zheng, Liping Huang, et al.. (2022). Human Recombinant Alkaline Phosphatase (Ilofotase Alfa) Protects Against Kidney Ischemia-Reperfusion Injury in Mice and Rats Through Adenosine Receptors. Frontiers in Medicine. 9. 931293–931293. 13 indexed citations

Primiano, Michael J., Bruce A. Lefker, Michael Bowman, et al.. (2016). Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. The Journal of Immunology. 197(6). 2421–2433. 143 indexed citations

Bree, Andrea G., et al.. (2013). A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway. Journal of Pharmacokinetics and Pharmacodynamics. 40(5). 609–622. 1 indexed citations

Bree, Andrea G., et al.. (2013). Development of a model of Ascaris Suum antigen-induced pulmonary inflammation in nonhuman primates. Journal of Inflammation. 10(S1). 1 indexed citations

Arai, Maya, Andrew A. Hill, Yongjing Guo, et al.. (2010). Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood. Journal of Translational Medicine. 8(1). 51–51. 6 indexed citations

Vugmeyster, Yulia, Scott W. Allen, Pamela Szklut, et al.. (2010). Correlation of pharmacodynamic activity, pharmacokinetics, and anti-product antibody responses to anti-IL-21R antibody therapeutics following IV administration to cynomolgus monkeys. Journal of Translational Medicine. 8(1). 41–41. 15 indexed citations

Chaudhary, Divya, Diane H. Boschelli, Andrea G. Bree, et al.. (2009). Characterization of a selective Protein Kinase C theta (PKCθ) inhibitor for blocking T Cell responses (93.21). The Journal of Immunology. 182(Supplement_1). 93.21–93.21. 1 indexed citations

Demers, Delia, Andrea G. Bree, Susan Fish, et al.. (2009). Specific blockade of protein kinase C (PKC)-theta with a small molecule antagonist attenuates lung inflammation in a mouse model of established allergic airway disease (140.21). The Journal of Immunology. 182(Supplement_1). 140.21–140.21. 3 indexed citations

Kasaian, Marion T., Xiangyang Tan, Lori Fitz, et al.. (2008). Interleukin-13 Neutralization by Two Distinct Receptor Blocking Mechanisms Reduces Immunoglobulin E Responses and Lung Inflammation in Cynomolgus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 325(3). 882–892. 39 indexed citations

10.

Bree, Andrea G., Franklin Schlerman, Lioudmila Tchistiakova, et al.. (2007). IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys. Journal of Allergy and Clinical Immunology. 119(5). 1251–1257. 59 indexed citations

11.

Schlerman, Franklin, et al.. (1996). Thrombopoietic Activity of Recombinant Human Interleukin 11 (rHuIL‐11) in Normal and Myelosuppressed Nonhuman Primates. Stem Cells. 14(5). 517–532. 40 indexed citations

12.

Bree, Andrea G., et al.. (1994). Multiple Effects on Peripheral Hematology Following Administration of Recombinant Human Interleukin 12 to Nonhuman Primates. Biochemical and Biophysical Research Communications. 204(3). 1150–1157. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact